{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:27:17Z","timestamp":1777350437308,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002235","name":"Blanche Moore Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002235","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ahj.2022.12.014","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T10:05:05Z","timestamp":1674036305000},"page":"149-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry"],"prefix":"10.1016","volume":"258","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6449-4535","authenticated-orcid":false,"given":"Ankeet S.","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori B.","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"de Lemos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Goodrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin A.","family":"Bohula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2022.12.014_bib0001","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in china","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2022.12.014_bib0002","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jacc.2020.05.007","article-title":"Acute myocardial injury at hospital admission is associated with all-cause mortality in COVID-19","volume":"76","author":"Ni","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2022.12.014_bib0003","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"Connors","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ahj.2022.12.014_bib0004","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2022.12.014_bib0005","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10456-021-09805-6","article-title":"COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects","volume":"24","author":"Smadja","year":"2021","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ahj.2022.12.014_bib0006","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/eurheartj\/ehaa623","article-title":"COVID-19 is, in the end, an endothelial disease","volume":"41","author":"Libby","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2022.12.014_bib0007","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1161\/CIRCULATIONAHA.120.050354","article-title":"Severe COVID-19 is a microvascular disease","volume":"142","author":"Lowenstein","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2022.12.014_bib0008","unstructured":"Homepage - COVID-19 protocols [Internet]. [cited 7 April 2022 ];Available from: https:\/\/covidprotocols.org\/en\/, accessed May 15, 2022."},{"key":"10.1016\/j.ahj.2022.12.014_bib0009","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.006967","article-title":"American Heart Association COVID-19 CVD registry powered by get with the guidelines","volume":"13","author":"Alger","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2022.12.014_bib0010","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2022.12.014_bib0011","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1093\/eurheartj\/ehaa1103","article-title":"C-reactive protein and clinical outcomes in patients with COVID-19","volume":"42","author":"Smilowitz","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2022.12.014_bib0012","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/CIRCULATIONAHA.120.053311","article-title":"Multiple biomarker approach to risk stratification in COVID-19","volume":"143","author":"Smilowitz","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2022.12.014_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-041295","article-title":"Association between biomarkers and COVID-19 severity and mortality: a nationwide Danish cohort study","volume":"10","author":"Hodges","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.ahj.2022.12.014_bib0014","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1161\/CIRCULATIONAHA.120.050089","article-title":"Established cardiovascular biomarkers provide limited prognostic information in unselected patients hospitalized with COVID-19","volume":"142","author":"Omland","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2022.12.014_bib0015","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1161\/CIRCULATIONAHA.120.050434","article-title":"Myocardial injury in adults hospitalized with COVID-19","volume":"142","author":"Smilowitz","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2022.12.014_bib0016","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ahj.2022.12.014_bib0017","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018477","article-title":"Troponin and other biomarker levels and outcomes among patients hospitalized with COVID-19: derivation and validation of the HA2T2 COVID-19 mortality risk score","volume":"10","author":"Manocha","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2022.12.014_bib0018","doi-asserted-by":"crossref","first-page":"e13532","DOI":"10.1111\/eci.13532","article-title":"Cardiac troponin and COVID-19 severity: results from BIOCOVID study","volume":"51","author":"Garc\u00eda de Guadiana-Romualdo","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ahj.2022.12.014_bib0019","doi-asserted-by":"crossref","first-page":"398","DOI":"10.14740\/cr1159","article-title":"Cardiac Troponin-I and COVID-19: a prognostic tool for in-hospital mortality","volume":"11","author":"Al Abbasi","year":"2020","journal-title":"Cardiol Res"},{"key":"10.1016\/j.ahj.2022.12.014_bib0020","article-title":"Predictive factor for COVID-19 worsening: insights for high-sensitivity troponin and D-Dimer and correlation with right ventricular afterload","volume":"7","author":"Goudot","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ahj.2022.12.014_bib0021","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/CIRCULATIONAHA.121.054969","article-title":"Prognostic value of natriuretic peptides & cardiac troponins in COVID-19","volume":"144","author":"Cunningham","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2022.12.014_bib0022","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008354","article-title":"Clinical characteristics and outcomes of adults with a history of heart failure hospitalized for COVID-19","volume":"14","author":"Goyal","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ahj.2022.12.014_bib0023","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchf.2020.11.003","article-title":"Clinical outcomes in patients with heart failure hospitalized with COVID-19","volume":"9","author":"Bhatt","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ahj.2022.12.014_bib0024","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(21)01203-4","article-title":"Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial","volume":"397","author":"Lopes","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2022.12.014_bib0025","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1001\/jama.2021.4152","volume":"325","author":"Sadeghipour","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2022.12.014_bib0026","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"Therapeutic anticoagulation with heparin in noncritically ill patients with COVID-19","volume":"385","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2022.12.014_bib0027","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically ill patients with COVID-19","volume":"385","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2022.12.014_bib0028","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1161\/CIRCULATIONAHA.122.061533","article-title":"Anticoagulation and antiplatelet therapy for prevention of venous and arterial thrombotic events in critically ill patients with COVID-19: COVID-Pact","volume":"146","author":"Bohula","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2022.12.014_bib0029","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jama.2021.23605","article-title":"Effect of P2Y12 inhibitors on survival free of organ support among non-critically ill hospitalized patients with COVID-19: a randomized clinical trial","volume":"327","author":"Berger","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2022.12.014_bib0030","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jacbts.2021.09.013","article-title":"Effect of Crizanlizumab, a P-selectin inhibitor, in COVID-19: a placebo-controlled, randomized trial","volume":"6","author":"Leucker","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.ahj.2022.12.014_bib0031","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/jth.14929","article-title":"Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19","volume":"18","author":"Spyropoulos","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ahj.2022.12.014_bib0032","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1161\/CIRCULATIONAHA.120.050360","article-title":"Growth differentiation factor 15 provides prognostic information superior to established cardiovascular and inflammatory biomarkers in unselected patients hospitalized with COVID-19","volume":"142","author":"Myhre","year":"2020","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870322003349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870322003349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:10:37Z","timestamp":1757571037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870322003349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":32,"alternative-id":["S0002870322003349"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2022.12.014","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2022.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}